Genomic Selection Platform Market Research Reveals Strong 16.8% CAGR Outlook Through 2030

The genomic selection platform industry is on the cusp of significant expansion, driven by technological innovations and increasing demand in agriculture and biotechnology. With advancements in genomics and data analytics, this sector is set to transform breeding programs and sustainable development efforts in the coming years. Let's explore the current market valuation, influential players, key trends, and segment breakdown within this rapidly evolving industry.

Projected Growth and Market Size of the Genomic Selection Platform Industry
The genomic selection platform market is anticipated to experience swift growth, reaching a valuation of $4.96 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 16.8%. Several factors contribute to this robust growth, including the increasing use of genomic selection techniques in agriculture, the rising application of predictive analytics in breeding initiatives, and a growing focus on sustainable crop and livestock development. Additionally, the integration of genomics with precision agriculture, along with advances in cloud-native genomic platforms, further propels market expansion. Notable trends driving this growth include wider adoption of AI-powered genomic prediction models, increased use of high-throughput genotyping technologies, incorporation of cloud-based analytics for breeding decisions, and enhanced accuracy in trait-based selection.

The genomic selection platform market size has grown rapidly in recent years. It will grow from $2.27 billion in 2025 to $2.66 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to expansion of molecular breeding programs, increasing availability of genotyping technologies, adoption of statistical genomics models, rising demand for faster breeding cycles, growing research investments in genetics.

Download a free sample of the genomic selection platform market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28237&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Key Drivers Behind the Expansion of the Genomic Selection Platform Market
One of the primary forces pushing this market forward is the growing acceptance of genomic selection methods within agricultural practices. These approaches help optimize breeding outcomes and improve crop and livestock traits, addressing global food security challenges.
Furthermore, advancements in predictive analytics and cloud computing are enabling more precise and efficient breeding programs. These technologies offer breeders valuable insights and support decision-making processes, making breeding faster and more cost-effective.

Leading Companies Shaping the Genomic Selection Platform Sector
Several prominent organizations dominate the genomic selection platform landscape. Key players include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GE Healthcare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., MGI Tech Co. Ltd., Azenta Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Ultima Genomics Inc., Element Biosciences Inc., DNAnexus Inc., Deep Genomics Inc., Epigene Labs Inc., Quotient Therapeutics Inc., Evogene Ltd., Nebula Genomics Inc., Verinomics Inc., InEdita Bio Inc., GenEmbryomics Inc., and Enigma Genomics Inc. These companies are at the forefront of innovation and product development within this space.

View the full genomic selection platform market report:
https://www.thebusinessresearchcompany.com/report/genomic-selection-platform-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Noteworthy Trends and Innovations Energizing the Genomic Selection Platform Industry
Market leaders are placing a strong emphasis on developing cutting-edge solutions like targeted sequencing platforms, which aim to enhance trait prediction and speed up breeding programs. These platforms focus on sequencing specific genomic regions rather than entire genomes, offering increased efficiency.
For instance, in October 2024, US-based Element Biosciences Inc. introduced Trinity, a revolutionary targeted sequencing platform. Trinity simplifies exome capture by embedding complex procedures directly into its AVITI System, eliminating the need for special equipment, cutting down manual labor by as much as five hours, and providing a one-hour hybridization option for same-day results. The platform supports customizable panels for various applications including oncology, respiratory diseases, and minimal residual disease (MRD), delivering faster, cost-effective, and more accessible sequencing solutions - a significant breakthrough in exome capture technology.

Detailed Breakdown of the Genomic Selection Platform Market Segments
This market is segmented based on multiple criteria for a comprehensive understanding of its structure:
1) Component: Software, Hardware, Services
2) Deployment Mode: On-Premises, Cloud-Based
3) Application: Plant Breeding, Animal Breeding, Human Genomics, Other Applications
4) End-User: Research Institutes, Biotechnology Companies, Agricultural Organizations, Other End-Users

Further subcategories include:
- Software types such as genomic data management tools, bioinformatics and statistical analysis software, DNA/RNA sequencing data processors, genomic prediction and modeling software, cloud-based genomic platforms, and workflow automation tools.
- Hardware offerings including next-generation sequencing (NGS) systems, polymerase chain reaction (PCR) instruments, microarray analyzers, high-performance computing (HPC) systems, data storage servers, and laboratory automation robotics.
- Services covering sequencing and genotyping, data analysis and interpretation, cloud hosting and storage, custom bioinformatics solutions, training and technical support, as well as consulting and implementation services.

This detailed segmentation highlights the diverse and growing facets of the genomic selection platform market, reflecting its potential to revolutionize breeding and genomics research globally.

Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.